Page 159 - Orange Book Cumulative Supplement 10 October 2012

A - 22
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content

PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
ICOSAPENT ETHYL - VASCEPA
N202057 001 8188146 Jan 27, 2020 DS DP
>A> 8293727 Feb 09, 2030 U-1287
>A> 8293728 Feb 09, 2030 U-1287
>A> 8298554 Apr 29, 2030 DP
IMATINIB MESYLATE - GLEEVEC
N021588 001 ODE Dec 19, 2015
IMATINIB MESYLATE - GLEEVEC
N021588 002 ODE Dec 19, 2015
IMIQUIMOD - ZYCLARA
N022483 001 8236816 Dec 11, 2029 U-68
>A> 8299109 Dec 11, 2029 U-68
IMIQUIMOD - ZYCLARA
N022483 002 8222270 Dec 11, 2029 U-68
INGENOL MEBUTATE - PICATO
N202833 001 6432452 Aug 19, 2018 DS U-68 NCE Jan 23, 2017
6844013 Aug 19, 2018 DS DP U-1221
7410656 Aug 19, 2018 DS U-1222
>A> 8278292 Feb 20, 2027 DS DP
INGENOL MEBUTATE - PICATO
N202833 002 6432452 Aug 19, 2018 DS U-68 NCE Jan 23, 2017
6844013 Aug 19, 2018 DS DP U-1221
7410656 Aug 19, 2018 DS U-1222
>A> 8278292 Feb 20, 2027 DS DP
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 70/30
N021172 001 5866538 Jun 19, 2017 DP
5866538*PED Dec 19, 2017

INSULIN DETEMIR RECOMBINANT - LEVEMIR
N021536 001 5750497 Jun 16, 2019 DS DP U-668 M-117 May 18, 2015
M-115 Apr 06, 2015
INSULIN LISPRO RECOMBINANT - HUMALOG
N020563 001 >A> NR Oct 12, 2015
INSULIN LISPRO RECOMBINANT - HUMALOG PEN
N020563 002 >A> NR Oct 12, 2015
IOFLUPANE I-123 - DATSCAN
N022454 001 5310912 Feb 25, 2013 DS
IRBESARTAN - IRBESARTAN
A077159 001 PC Sep 26, 2012
IRBESARTAN - IRBESARTAN
A077159 002 PC Sep 26, 2012
IRBESARTAN - IRBESARTAN
A077159 003 PC Sep 26, 2012
IRON SUCROSE - VENOFER
N021135 001 NPP Sep 21, 2015
IRON SUCROSE - VENOFER
N021135 002 NPP Sep 21, 2015